Skip to main content
SpringerLink
Log in
Book cover

Valuation in Life Sciences

A Practical Guide

  • Book
  • © 2008

Overview

Authors:
  1. Boris Bogdan

    1. Avance Basel GmbH, CH-4051, Switzerland

    View author publications

    You can also search for this author in PubMed   Google Scholar

  2. Ralph Villiger

    1. Avance Basel GmbH, CH-4051, Switzerland

    View author publications

    You can also search for this author in PubMed   Google Scholar

  • First complete guide to valuation in life sciences (pharma, biotech, medtech)
  • Step-by-step explanation of how to practice valuation of projects and contracts
  • With relevant data and many real-life examples and exercises
  • Includes supplementary material: sn.pub/extras

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (6 chapters)

  1. Front Matter

    Pages i-xi
    Download chapter PDF

  2. Introduction

    Pages 1-9

  3. Fundamentals in Life Sciences

    Pages 11-26

  4. Basics of Valuation

    Pages 27-81

  5. Valuation in Life Sciences

    Pages 83-284

  6. Exercises

    Pages 285-309

  7. Case Studies

    Pages 311-325

  8. Back Matter

    Pages 327-334
    Download chapter PDF
Back to top

Keywords

About this book

Valuation is a hot topic among life sciences professionals. There is no clear understanding on how to use the different valuation approaches and how to determine input parameters. Some do not value at all, arguing that it is not possible to get realistic and objective numbers out of it. Some claim it to be an art. In the following chapters we will provide the user with a concise val- tion manual, providing transparency and practical insight for all dealing with valuation in life sciences: project and portfolio managers, licensing executives, business developers, technology transfer managers, entrep- neurs, investors, and analysts. The purpose of the book is to explain how to apply discounted cash flow and real options valuation to life sciences p- jects, i.e. to license contracts, patents, and firms. We explain the fun- mentals and the pitfalls with case studies so that the reader is capable of performing the valuations on his own and repeat the theory in the exercises and case studies. The book is structured in five parts: In the first part, the introduction, we discuss the role of the players in the life sciences industry and their p- ticular interests. We describe why valuation is important to them, where they need it, and the current problems to it. The second part deals with the input parameters required for valuation in life sciences, i.e. success rates, costs, peak sales, and timelines.

Reviews

From the reviews:

"‘Valuation in Life Sciences: A Practical Guide’ leads readers step by step through the theory of life sciences valuation. … it is an important read for biotech investors. … It is the first book of its kind that combines industry data and valuation theory together with practical advice. It includes valuation techniques and tools that allow investors to pick undervalued biotech stocks." (GEN – genetic engineering news, February, 2007)

"Valuation in Life Sciences: A Practical Guide opens up the black box and describes, step by step, a relatively simple procedure for quantitative valuation in life sciences. The book guides the reader through the recommended procedure of quantitative valuation … . This book is recommended to those who would like to acquire a profound understanding of quantitative valuation and use a simple spreadsheet approach of their own cases." (Rudolf Gygax, Nature Biotechnology, Vol. 25 (9), 2007)

"This book provides some interesting examples – for business development and licensing executives – of where ROV may be used. … For the general reader and business development executive there is a good explanation of ROV and its applications in life science … . The book may also be of interest to biotechnology company business development executives and university technology transfer officers … . this book is essential reading as it not only provides the mathematical theory but also the applications in different types of deals." (Roger Davies, Business Development & Licensing Journal, Issue 4, 2007)

Authors and Affiliations

  • Avance Basel GmbH, CH-4051, Switzerland

    Boris Bogdan, Ralph Villiger

Bibliographic Information

Publish with us

Policies and ethics

Back to top

Search

Navigation